Analyst Downgrades: Valeant Pharmaceuticals Intl Inc, Lumentum Holdings Inc, and Orbital ATK Inc

Analysts downwardly revised their ratings and price targets on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Lumentum Holdings Inc (NASDAQ:LITE), and Orbital ATK Inc (NYSE:OA)

Josh Selway

Aug 11, 2016 at 9:27 AM

oa
lite
VRX

Analysts are weighing in on biotech stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX), optical products specialist Lumentum Holdings Inc (NASDAQ:LITE), and defense stock Orbital ATK Inc (NYSE:OA). Here's a quick roundup of today's bearish brokerage notes on VRX, LITE, and OA.

VRX is looking at a 9% drop when the market opens, on news the company is being investigated for possibly defrauding insurers by hiding its relationship with "phantom pharmacy" Philidor. Meanwhile, Wells Fargo has reiterated its "underperform" rating, saying about the investigation, "the risks not only include reputational harm, but include potential financial damages and fines, and also potential commercial sanctions or restrictions." Valeant Pharmaceuticals Intl Inc closed last night at $27.32, unable to take advantage of a rare round of positive analyst attention. Most analysts are on the fence when it comes to the long-time underperformer, with the majority of covering firms handing out a "hold" rating.

Morgan Stanley joined a number of brokerage firms that yesterday raised their price targets on LITE post-earnings, upping its mark to $27 from $20. However, the firm also downgraded the stock's rating to "underweight" from "equal weight." The bearish note comes despite Lumentum Holdings Inc's 44.5% year-to-date gain, with the shares settling at $31.82 on Wednesday, after touching a record high earlier in the session. In the meantime, call buying has dominated the options pits, as LITE's 50-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) comes in at 3.09.

OA has edged 1.6% higher ahead of the bell, looking to bounce back from yesterday's steep decline. The stock will need to overcome price-target cuts from Credit Suisse and Barclays, which reduced their respective marks to $86 and $97. Orbital ATK Inc could now find round-number support at the $70 mark, as it closed Wednesday at $70.79. Nonetheless, there's a chance additional bearish notes could weigh on the shares, since six of the seven covering analysts rate them a "strong buy," with zero "sells" on the books.

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

Follow @Schaeffers

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.